2019
DOI: 10.2116/analsci.19r002
|View full text |Cite
|
Sign up to set email alerts
|

An Exploration of Advancement in Analytical Methodology for Quantification of Anticancer Drugs in Biomatrices

Abstract: Significant numbers of newer anticancer drugs are regularly entering into the market worldwide to fight against different types of cancers. Analytical methodologies are being developed to quantitate those molecules in a variety of matrices during their drug development stages. Selection of biological matrices for developing bioanalytical methods is based on the mechanism of action, site of action, site of metabolism and route of excretion of the drugs or their metabolites. In this review, we have described the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 92 publications
(85 reference statements)
0
11
0
Order By: Relevance
“…26 It has been reported that some developed analytical methodologies could quantify the anticancer drugs of cell lines which might help to further clarify the NO's function. 27 The sequence in the addition of Dox and Arg is critical for the augmentation in the Dox effect…”
Section: Arg Augmented Cytotoxicity Of Dox To Cancer Cellmentioning
confidence: 99%
“…26 It has been reported that some developed analytical methodologies could quantify the anticancer drugs of cell lines which might help to further clarify the NO's function. 27 The sequence in the addition of Dox and Arg is critical for the augmentation in the Dox effect…”
Section: Arg Augmented Cytotoxicity Of Dox To Cancer Cellmentioning
confidence: 99%
“…35 In other words, a full-scan acquisition would eliminate the need for sample preparation and enable the collection of quantitative (at ng/mL to pg/mL level) as well as qualitative information. 3 In recent years, a shift in drug discovery approach from SRM to nontargeted HRMS has been seen, which enables simultaneous parent drug quantitation and identification of metabolite and biomarker in biofluids. 35,36 The innovation in hybrid mass analyzers with higher resolving power and mass accuracy, advancement in ionization sources, development of novel LC columns and database for structural elucidation are being well explored for regulated bioanalysis.…”
Section: Strategy For Selection Of Lc-ms/ms In Bioanalysismentioning
confidence: 99%
“…The extent of matrix influence needs to be evaluated to acquire more precise and accurate bioanalytical data. 3,20 Matrix effects can be compensated or reduced by applying a combination of strategies regardless of instrumental parameters. Various specific approaches include the use of hybrid mass analyzer and modification in sample extraction procedure by derivatizing the compound of interest.…”
Section: Matrix Effects In Lc-msmentioning
confidence: 99%
See 1 more Smart Citation
“…Globally, researchers are engaged in a continuous effort to discover anticancer drugs with a much higher safety profile (Jain et al 2019;Sharma et al 2019). Postmarketing surveillance of any drugs depends on its acceptability based on risk to benefit ratio.…”
Section: Introductionmentioning
confidence: 99%